Startup
Comprising a team of passionate researchers committed to stem cell cultivation, the company aims to push its products as the future standard for stem cell culture by providing high-quality and certified stem cell culture media. Drawing on basic research to build a market presence, the startup aims to attain mass production of both 2D and 3D cultures and provide technological services for stem cell cultivation, thereby competing in the international cellular therapy market.
Guidance Rendered
-

- Counseling on regulatory classification and grading and premarket pathway; guidance on the startup’s DMF submission to the FDA.
- Matching for marketing endeavors and capital solicitation.
- Conducting interviews with senior executives to pinpoint the market needs and niches the startup should aim for; consultation on its joining construction of a new plant in the Hsinchu Biomedical Science Park in Zhubei.